BACKGROUND: Vitamin D deficiency is repeatedly reported in colorectal cancer (CRC). Since cholesterol and vitamin D share common precursor 7-dehydrocholesterol (7-DHC), it would be important to explore the associations of key vitamin D metabolites and serum lipid parameters in patients with high and low grade CRC. The aim of this study was to analyze relationships between serum 25(OH)D3, 24,25(OH)2D3 and 7-DHC levels and serum lipids in patients with CRC, and to evaluate their potential for prediction of risk for development of high grade CRC. METHODS: We recruited 82 patients CRC and 77 controls. 7-DHC, 25(OH)D3 and 24,25(OH)2D3 were quantified by LC-MS/MS methods. RESULTS: 7-DHC, 25(OH)D3 and vitamin D metabolic ratio (VDMR) were significantly lower in CRC patients than in control group (P<0.001, P<0.010, P<0.050 and P<0.050, respectively). 25(OH)D3 levels were higher in patients with grade I CRC when compared to grade II (P<0.050). All vitamin D metabolites positively correlated with total cholesterol (TC) concentration in CRC patients. 25(OH)D3 was significant predictor of increased CRC risk (P<0.010). After adjustment for TC concentration, 25(OH)D3 lost its predictive abilities. However, 25(OH)D3 remained significant predictor of poorly differentiated type of cancer (P<0.050). CONCLUSIONS: We found significant positive association between vitamin D status and serum total cholesterol. Although low 25(OH)D3 was found to be a significant risk factor for CRC development, the obtained results primarily suggest profound impact of cholesterol level on vitamin D status in CRC. However, our results suggest that low 25(OH)D3 might independently contribute to development of poorly differentiated tumor. 2020 Sandra Vladimirov, Aleksandra Zeljković, Tamara Gojković, Milica Miljković, Aleksandra Stefanović, Dejan Zeljković, Bratislav Trifunović, Vesna Spasojević-Kalimanovska, published by CEON/CEES.
BACKGROUND: Vitamin D deficiency is repeatedly reported in colorectal cancer (CRC). Since cholesterol and vitamin D share common precursor 7-dehydrocholesterol (7-DHC), it would be important to explore the associations of key vitamin D metabolites and serum lipid parameters in patients with high and low grade CRC. The aim of this study was to analyze relationships between serum 25(OH)D3, 24,25(OH)2D3 and 7-DHC levels and serum lipids in patients with CRC, and to evaluate their potential for prediction of risk for development of high grade CRC. METHODS: We recruited 82 patients CRC and 77 controls. 7-DHC, 25(OH)D3 and 24,25(OH)2D3 were quantified by LC-MS/MS methods. RESULTS: 7-DHC, 25(OH)D3 and vitamin D metabolic ratio (VDMR) were significantly lower in CRC patients than in control group (P<0.001, P<0.010, P<0.050 and P<0.050, respectively). 25(OH)D3 levels were higher in patients with grade I CRC when compared to grade II (P<0.050). All vitamin D metabolites positively correlated with total cholesterol (TC) concentration in CRC patients. 25(OH)D3 was significant predictor of increased CRC risk (P<0.010). After adjustment for TC concentration, 25(OH)D3 lost its predictive abilities. However, 25(OH)D3 remained significant predictor of poorly differentiated type of cancer (P<0.050). CONCLUSIONS: We found significant positive association between vitamin D status and serum total cholesterol. Although low 25(OH)D3 was found to be a significant risk factor for CRC development, the obtained results primarily suggest profound impact of cholesterol level on vitamin D status in CRC. However, our results suggest that low 25(OH)D3 might independently contribute to development of poorly differentiated tumor. 2020 Sandra Vladimirov, Aleksandra Zeljković, Tamara Gojković, Milica Miljković, Aleksandra Stefanović, Dejan Zeljković, Bratislav Trifunović, Vesna Spasojević-Kalimanovska, published by CEON/CEES.
Entities:
Keywords:
24,25-dihydroxyvitamin D; 25-hydroxyvitamin D; 7-dehydrocholesterol; colorectal cancer; total cholesterol
Authors: Martin Kaufmann; J Christopher Gallagher; Munro Peacock; Karl-Peter Schlingmann; Martin Konrad; Hector F DeLuca; Rita Sigueiro; Borja Lopez; Antonio Mourino; Miguel Maestro; René St-Arnaud; Joel S Finkelstein; Donald P Cooper; Glenville Jones Journal: J Clin Endocrinol Metab Date: 2014-03-26 Impact factor: 5.958
Authors: Shaneda Warren Andersen; Xiao-Ou Shu; Qiuyin Cai; Nikhil K Khankari; Mark D Steinwandel; Peter W Jurutka; William J Blot; Wei Zheng Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-05-08 Impact factor: 4.254
Authors: Chetna Sharon; Somesh Baranwal; Nirmita J Patel; Daniel Rodriguez-Agudo; William M Pandak; Adhip P N Majumdar; Geoffrey Krystal; Bhaumik B Patel Journal: Oncotarget Date: 2015-06-20
Authors: Yazhou He; Maria Timofeeva; Susan M Farrington; Peter Vaughan-Shaw; Victoria Svinti; Marion Walker; Lina Zgaga; Xiangrui Meng; Xue Li; Athina Spiliopoulou; Xia Jiang; Elina Hyppönen; Peter Kraft; Douglas P Kiel; Caroline Hayward; Archie Campbell; David Porteous; Katarina Vucic; Iva Kirac; Masa Filipovic; Sarah E Harris; Ian J Deary; Richard Houlston; Ian P Tomlinson; Harry Campbell; Evropi Theodoratou; Malcolm G Dunlop Journal: BMC Med Date: 2018-08-14 Impact factor: 8.775